UOC Nefrologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Renal Unit, Department of Medicine, University Hospital of Verona, Verona, Italy.
Urolithiasis. 2019 Feb;47(1):115-123. doi: 10.1007/s00240-018-1092-4. Epub 2018 Nov 23.
Deciding whether to accept a donor with nephrolithiasis is a multifaceted task because of the challenge of finding enough suitable donors while at the same time ensuring the safety of both donors and recipients. Until not long ago, donors with a history of renal stones or with stones emerging during screening on imaging were not considered ideal, but recent guidelines have adopted less stringent criteria for potential donors at risk of stones. This review goes through the problems that need to be approached to arrive at a wise clinical decision, balancing the safety of donors and recipients with the need to expand the organ pool. The risk of declining renal function and worsening stone formation is examined. Documents (consensus statements, guidelines, etc.) on this issue released by the most important medical societies and organizations are discussed and compared. Specific problems of living kidney donation associated with certain systemic (chronic hypercalcemia due to CYP24A1 gene mutations, primary hyperoxaluria, APRT deficiency) and renal (medullary sponge kidney, cystinuria, distal renal tubular acidosis, Dent's disease, Bartter syndrome, familial hypomagnesemia with hypercalciuria and nephrocalcinosis) Mendelian disorders that cause nephrolithiasis are also addressed.
决定是否接受患有肾结石的供体是一项多方面的任务,因为在寻找足够多合适供体的同时,还需要确保供体和受者的安全。直到不久前,有肾结石病史或在影像学筛查中出现结石的供体都不被认为是理想的,但最近的指南对于有结石风险的潜在供体采用了不那么严格的标准。这篇综述探讨了需要解决的问题,以做出明智的临床决策,在平衡供体和受者的安全性与扩大器官库的需求之间取得平衡。检查了肾功能下降和结石形成恶化的风险。讨论并比较了最重要的医学协会和组织发布的关于这个问题的文件(共识声明、指南等)。还讨论了与某些系统性疾病(由于 CYP24A1 基因突变导致的慢性高钙血症、原发性高草酸尿症、APRT 缺乏症)和肾脏疾病(髓质海绵肾、胱氨酸尿症、远端肾小管酸中毒、Dent 病、Bartter 综合征、家族性低镁血症伴高钙尿和肾结石)相关的活体肾脏捐献的具体问题,这些疾病会导致肾结石。